bpc 157 legality BPC-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank Breaking News: FDA Unbans 14

But it also means that the protocol as a whole has almost never been studied, and the evidence for each individual component varies from moderate to essentially nonexistent

Medications that may impact B12 levels Proton pump inhibitors (PPIs)

The parenteral administration also halts the progression of neurological damage associated with B12 deficiency, but the complete improvement of the condition may depend on the severity and extent of the deficiency.[12][13] Contraindications & Precautions Cyanocobalamin is contraindicated in those with hypersensitivity to cobalt moiety or cobalamin molecule due to the risk of anaphylaxis.[21] Warnings: The use of cyanocobalamin is warned in patients with early Lebers disease as there have been reports of severe and swift optic atrophy with its administration

Some key features and benefits of tirzepatide include: 1